Does USTEKINUMAB Cause Product label issue? 164 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Product label issue have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
164
Reports of Product label issue with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product label issue From USTEKINUMAB?
Of the 164 reports, 5 (3.0%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Product label issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Product label issue?
RIVAROXABAN (379)
ACETAMINOPHEN (276)
GUSELKUMAB (177)
DIMETHICONE\LOPERAMIDE (154)
CETIRIZINE (138)
IBUPROFEN (99)
GOLIMUMAB (76)
POLYETHYLENE GLYCOL 3350 (76)
FENTANYL (72)
LOPERAMIDE (72)
Which USTEKINUMAB Alternatives Have Lower Product label issue Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE